Literature DB >> 31202088

Generalised morphea induced by pembrolizumab.

Hugo Herrscher1, Gorana Tomasic2, Alicia Castro Gordon3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31202088     DOI： 10.1016/j.ejca.2019.05.018

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  2 in total

1.  Generalized morphoea in the setting of combined immune checkpoint inhibitor therapy for metastatic melanoma: A case report.

Authors:  Ewan A Langan; Kaja Budner; Detlef Zillikens; Patrick Terheyden
Journal:  Medicine (Baltimore)       Date:  2021-04-23       Impact factor: 1.817

Review 2.  Dermatologic immune-related adverse events: The toxicity spectrum and recommendations for management.

Authors:  Zoe Apalla; Bernardo Rapoport; Vincent Sibaud
Journal:  Int J Womens Dermatol       Date:  2021-10-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.